A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Field Reimbursement Manager - Great Lakes North

Clinical Support & Patient AdministrationConfirmed live in the last 24 hours
Full-time$123.3k - $166.8k

About the Job

Requirements

  • A bachelor's degree is required; equivalent experience may include 1.5 or more years as a field reimbursement specialist, 2 years in specialty pharmaceutical medical benefit sales, or 2 or more years as a biologic coordinator or office practice manager.
  • Experience navigating prior authorization and appeals processes for pharmacy and medical benefit coverage is required.
  • Proven experience working with Hubs and a strong understanding of Hub activities, including prior authorization, appeals, and payer-specific access processes, are required.
  • Knowledge of commercial payers, Medicare plans, and state Medicaid programs within the assigned geography is required.
  • A valid driver's license and ability to travel, including overnight and/or weekend travel as required, are required.

Responsibilities

  • Analyze payer criteria and access requirements across medical and pharmacy benefit designs.
  • Identify and address access barriers that may affect time to treatment.
  • Provide healthcare provider offices with product access expertise, including education on reimbursement pathways, coverage requirements, prior authorization, appeals, and payer processes.
  • Partner with colleagues to support consistent patient services education and coordinated field execution.
  • Educate healthcare providers and office staff on Alnylam Assist enrollment, program offerings, missing information requirements, reimbursement resources, financial assistance, and Hub tools.
  • Liaise with Specialty Pharmacy Account Liaisons, as appropriate, for products covered under the pharmacy benefit.
  • Monitor and communicate relevant commercial, Medicare, Medicaid, and government payer coverage updates that may affect patient access in the assigned geography, and serve as a subject matter expert on relevant territory payers.

Desired Qualifications

  • Cardiology or rare disease experience is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs